Boston Scientific (BSX) PT Raised to $26 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Boston Scientific (BSX) PT Raised to $23.50 at Evercore ISI
April 27, 2016 1:02 PM EDTEvercore ISI analyst Vijay Kumar raised estimates and his price target on Boston Scientific (NYSE: BSX) to $23.50 (from $21.50) due to market multiple expansion. The firm maintained a Buy rating.
FY16 EPS was raised from $1.06 to $1.11 mainly due to higher organic revenue growth (mainly from... More
Boston Scientific (BSX) Gains Following Strong Results, Outlook
April 27, 2016 9:53 AM EDTBoston Scientific (NYSE: BSX) is strong out of the gate following better-than-expected earnings and a raised outlook. Shares last traded up 8.9%.
Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the... More
Boston Scientific (BSX) Tops Q1 EPS by 4c; Boosts FY16 Outlook
April 27, 2016 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $1.96 billion versus the consensus estimate of $1.91 billion.
GUIDANCE:
Boston Scientific sees Q2 2016 EPS of $0.25-$0.27, versus the consensus of $0.26.... More
